Phthalates: Toxicology and exposure

International Journal of Hygiene and Environmental Health

Volumn 210, Issue 5, 2007, Pages 623-634

  Heudorf, Ursel ^a   Mersch Sundermann, Volker ^b   Angerer, Jürgen ^c  

^a Public Health Services of the City of Frankfurt on the Main   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Exposure assessment; Human biomonitoring; Phthalates; Toxicology

Indexed keywords

ANIMALIA;

EID: 35148892258     PISSN: 14384639     EISSN: 1618131X     Source Type: Journal    
DOI: 10.1016/j.ijheh.2007.07.011     Document Type: Article

References (83)

1. Albro P.W., and Moore B. Identification of the metabolites of simple phthalate esters in rat urine. J. Chromatogr. 94 (1974) 209-218
2. ATSDR. Toxicological Profile for Diethylphthalate (1995), Agency for Toxic Substances and Disease, Atlanta, GA
3. ATSDR. Toxicological Profile for Di-n-Octylphthalate (1997), Agency for Toxic Substances and Disease Registry, Atlanta, GA
4. ATSDR. Toxicological Profile for Di-n-Butyl Phthalate (2001), Agency for Toxic Substances and Disease, Atlanta, GA
5. ATSDR. Toxicological Profile for Di(2-ethylhexyl)Phthalate (2002), Agency for Toxic Substances and Disease, Atlanta, GA
6. Barr D.B., Silva M.J., Kato K., Reidy J.A., Malek N.A., Hurtz D., Sadowski M., Needham L.L., and Calafat A.M. Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers. Environ. Health Perspect. 111 (2003) 1148-1151
7. Becker K., Seiwert M., Kraus S., et al. German Environmental Survey 1998 (GerES III): pesticides and other pollutants in housedust. Proceeding of the Ninth International Conference on Indoor Air and Climate (Indoor Air 02) 4 (2002) 883-887
8. Becker K., Seiwert M., Angerer J., Heger W., Koch H.M., Nagorka R., Rosskamp E., Schlüter C., Seifert B., and Ullrich D. DEHP metabolites in urine of children and DEHP in house dust. Int. J. Hyg. Environ. Health 207 (2004) 409-417
9. Blount B.C., Silva M.J., Caudill S.P., Needham L.L., Pirkle J.L., Sampson E.J., Lucier G.W., Jackson R.J., and Brock J.W. Levels of seven urinary phthalate metabolites in a human reference population. Environ. Health Perspect. 108 (2000) 979-982
10. Calafat A.M., Needham L.L., Silva M.J., and Lambert G. Exposure to di-(2-ethylhexyl) phthalate among premature neonates in a neonatal intensive care unit. Pediatrics 113 (2004) e429-e434
11. CDC, 2003. Second national report on human exposure to environmental chemicals. NCEH Pub No. 02-0716. Centers for Disease Control and Prevention, National Center for Environmental Health, Atlanta GA, 〈www.cdc.gov/exposurereport〉.
12. CDC, 2005. Third national report on human exposure to environmental chemicals, July 2005, 〈www.cdc.gov/exposurereport/3rd/pdf/thirdreport.pdf〉.
13. COM, European Commission, 1999. Official Journal L 315, 09/12/1999, pp. 46-49.
14. CSTEE (Scientific Committee on Toxicity, Ecotoxicity and the Environment), 1998a. Phthalate migration from soft PVC toys and child-care articles. Opinion expressed at the CSTEE third plenary meeting, Brussels, April 24, 1998.
15. CSTEE, Scientific Committee on Toxicity, Ecotoxicity and the Environment, 1998b. Opinion on phthalate migration from soft PVC toys and child-care articles-Date made available since the 16th of June 1998, opinion expressed at the Sixth CSTEE Plenary Meeting, Brussels, 26/27 November 1998.
16. CSTEE, Scientific Committee on Toxicity, Ecotoxicity and the Environment, 2004. Opinion on the results of a second risk assessment of bis(2-ethylhexyl)phthalate (DEHP) in human health part. Adopted by the CSTEE during the 41th Plenary Meeting of 8 January 2004.
17. Duty S.M., Calafat A.M., Silva M.J., Ryan L., and Hauser R. Phthalate exposure and reproductive hormones in adult men. Hum. Reprod. 20 (2005) 604-610
18. ECB (European Chemicals Bureau), 2004. Risk assessment report for bis(2-ethylhexyl)phthalate (DEHP consolidated Final Report: February 2004). Document No. R042_0402_env_hh_4-6.
19. EC-CHCPD (European Commission Health and Consumer Protection Directorate-General), 2002. Opinion on medical devices containing DEHP plasticised PVC; neonates and other groups possibly at risk from DEHP toxicity. Adopted by the Scientific Committee on Medical Products and Medical Devices on 26 September 2002.
20. ECPI (European Council for Plasticicers and Intermediates), 2004. Personal communication between D.F. Cadogan, Director of ECPI secretariat Brussels, and H.N. Koch researcher at the University of Nuremberg-Erlangen, March 2004.
21. EFSA (European Food Safety Authority), 2004. Statement on the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC Panel) on the reclassification of some phthalates for consistency with the new SCF guidelines for food contact materials, 26 May 2004, 〈www.efsa.europa.eu/de/science/scientific_reports/phthalates.html〉.
22. Fromme H., Lahrz T., Piloty M., Gebhart H., Oddoy A., and Rüden H. Occurrence of phthalates and musk fragrances in indoor air and dust from apartments and kindergartens in Berlin (Germany). Indoor Air 14 (2004) 188-195
23. Fromme H., Bolte G., Koch H.M., Angerer J., Boehmer S., Drexler H., Mayer R., and Liebl B. Occurrence and daily variation of phthalate metabolites in the urine of an adult population. Int. J. Hyg. Environ. Health 210 (2007) 21-33
24. Hauser R., Duty S., Godfrey-Bailey L., and Calafat A.M. Medications as a source of human exposure to phthalates. Environ. Health Perspect. 112 (2004) 751-753
25. Health Canada, 1994. Priority substances list. Assessment report: bis(2-ethylhexyl) phathalate. Government of Canada, Environment Canada, Health Canada, 〈http://www.hc-sc.gc.ca/hecs-sesc/exsd/pdf/bis_2_ethylhexyl_phthalate.pdf〉.
26. Health Canada, 2002. DEHP in medical devices: an exposure and toxicity assessment. Medical Devices Bureau, Therapeutic Products Directorate, Health Products and Fodd Branch, Health Canada, Ottawa, Canada.
27. Holstrup O., and Butte W. Endocrin Wirksame Xenobiotika in Haushalten. Konzentrationen in der Luft und im Hausstaub (2001), Bericht im Auftrag des Niedersächsischen Ministeriums für Frauen, Arbeit und Soziales, Oldenburg
28. IARC (International Agency for Research on Cancer). Some industrial chemicals. IARC Monographs 77 (2000) 41-148
29. IRIS, 2001. Integrated Risk Information System: di(2-ethylhexyl)phthalate, 〈http://www.epa.gov/subst/0014.htm〉.
30. Karle V., Short B., Martin G., Bulas D., Geston P., Luban N., O'Brien A., Rubin R., et al. Extracorporal membrane oxygenation exposes infants to the plasticizer, di(2ethylhexyl) phthalate. Critical Care Med. 25 (1997) 696-703
31. Kato K., Silva M.J., Brock J.W., Reidy J.A., Malek N.A., Hodge C.C., Nakazawa H., Needham L.L., and Barr D.B. Quantitative detection of nine phthalate metabolites in human serum using reversed-phase high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. J. Anal. Toxicol. 27 (2003) 284-289
32. Kato K., Silva M., Reidy J.A., Hurtz D., Malek N.A., Needham L.L., Nakazawa H., Barr D.B., and Calafat A. Mono (2-Ethyl-5-hydroxyhexyl) phthalate and mono (2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl)phthalate. Environ. Health Perspect. 112 (2004) 327-330
33. Kavlock R., Boekelheide K., Chapin R., Cunningham M., Faustman E., Foster P., Golub M., Henderson R., Hinberg I., Little R., Seed J., Shea K., Tabacova S., Tyl R., Williams P., and Zacharewski T. NTP center for the evaluation of risks to human reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di(2-ethylhexyl) phthalate. Reprod. Toxicol. 16 (2002) 529-653
34. Kersten N.E., and Reich T. Schwer flüchtige organische Umweltchemikalien in Hamburger Hausstäuben. Gefahrst. Reinh. Luft 63 (2003) 85-91
35. Koch H.M., Gonzalez-Reche L.M., and Angerer J. On-line cleanup by multidimensional LC-ESI-MS/MS for high throughput quantification of primary and secondary phthalate metabolites in human urine. J. Chromatogr. B 784 (2003) 169-182
36. Koch H.M., Drexler H., and Angerer J. An estimation of the daily intake of di(2-ethylhexyl)phthalate (DEHP) and other phthalates in the general population. Int. J. Hyg. Environ. Health 206 (2003) 77-83
37. Koch H.M., Drexler H., and Angerer J. Internal exposure of nursery-school children and their parents and teachers to di(2-ethylhexyl)phthalate (DEHP). Int. J. Hyg. Environ. Health 207 (2004) 15-22
38. Koch H.M., Bolt H., and Angerer J. Di(2-ethylhexyl)phthalate (DEHP) metabolites in human urine and serum after single oral dose of deuterium labelled DEHP. Arch. Toxicol. 78 (2004) 120-130
39. Koch H.M., Bolt H.M., Preuss R., and Angerer J. New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP. Arch. Toxicol. 79 (2005) 367-376
40. Koch H.M., Angerer J., Drexler H., Eckstein R., and Weisbach V. Di(2-ethylhexyl)phthalate (DEHP) exposure of voluntary plasma and platelet donors. Int. J. Hyg. Environ. Health 208 (2005) 489-498
41. Koch H.M., Bolt H.M., Preuss R., Eckstein R., Weisbach V., and Angerer J. Intravenous exposure to di(2-ethylhexyl)phthalate (DEHP): metabolites of DEHP in urine after a voluntary platelet donation. Arch. Toxicol. 79 (2005) 689-693
42. Koch H.M., Preuss R., Drexler H., and Angerer J. Exposure of nursery school children and their parents and teachers to di-n-butylphthalate and butylbenzylphthalate. Int. Arch. Occup. Environ. Health 78 (2005) 223-229
43. Koch H.M., Müller J., Drexler H., and Angerer J. Dibutylphthalat (DBP) in Arzneimitteln: ein bisher unterschätztes Risiko für Schwangere und Kleinkinder?. Umweltmed. Forsch. Prax. 10 (2005) 144-146
44. Koch H.M., Preuss R., and Angerer J. Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure - an update and latest results. Int. J. Androl. 29 (2006) 155-165 discussion 181-185
45. Latini G., De Felice C., and Verrotti A. Plasticizers, infant nutrition and reproductive health. Reprod. Toxicol. 19 (2004) 27-33
46. Marsee K., Woodruff T.J., Axelrad D.A., Calafat A.M., and Swan S.H. Estimated daily phthalate exposures in a population of mothers of male infants exhibiting reduced anogenital distance. Environ. Health Perspect. 114 (2006) 805-809
47. Meek M.E., and Chan P.K.L. Bis(2-ethylhexyl)phthalate: evaluation of risks to health from environmental exposure in Canada. J. Environ. Sci. Health Part C 12 (1994) 179-194
48. NTP-CERHR, 2000. NTP-CERHR expert panel report on di(2-ethylhexyl) phthalate. NTP-CERHR-DEHP.
49. NTP-CERHR, 2003a. Monograph on the potential human reproductive and developmental effects of di-isononyl phthalate (DINP). NIH Publ No. 03-4484.
50. NTP-CERHR, 2003b. Monograph on the potential human reproductive and developmental effects of di-isodecyl phthalate (DIDP). NIH Publ No. 03-4485.
51. NTP-CERHR, 2003c. Monograph on the potential human reproductive and developmental effects of di-n-butyl phthalate (DBP). NIH Publ No. 03-4486.
52. NTP-CERHR, 2003d. Monograph on the potential human reproductive and developmental effects butyl benzyl phthalate (BBP). NIH Publ No. 03-4487.
53. NTP-CERHR, 2003e. Monograph on the potential human reproductive and developmental effects of di-n-octyl phthalate (DnOP). NIH Publ No. 03-4488.
54. NTP-CERHR, 2003f. Monograph on the potential human reproductive and developmental effects of di-n-hexyl phthalate (DnHP). NIH Publ No. 03-4489.
55. NTP-CERHR, 2005. Expert panel re-evaluation of DEHP, Meeting summary, October 14, 2005, 〈www.noharm.org/details.cfm?ID=1130&type=document〉.
56. Page B.D., and Lacroix G.M. The occurrence of phthalate ester and di-2-ethylhexyl adipate plasticizers in Canadian packaging and food sampled in 1985-1989: a survey. Food Addit. Contam. 12 (1995) 129-151
57. Petersen J.H., and Breindahl T. Plasticizers in total diet samples, baby food and infant formulae. Food Addit. Contam. 17 (2000) 133-141
58. Pöhner A., Simrock S., Thumulla J., Weber S., and Wirkner T. Hintergrundbelastung des Hausstaubs von Privathaushalten mit mittel- und schwerflüchtigen organischen Schadstoffen. Z. Umweltmed. 6 (1998) 337-345
59. Preuss R., Koch H.M., and Angerer J. Biological monitoring of the five major metabolites of di-(2-ethylhexyl)phthalate (DEHP) in human urine using column - switching liquid chromatography - tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 816 1-2 (2005) 269-280
60. Rais-Bahrami K., Nunez S., Revenis M.E., Luban N.L., and Short B.L. Follow-up study of adolescents exposed to di(2-ethylhexyl) phthalate (DEHP) as neonates on extracorporeal membrane oxygenation (ECMO) support. Environ. Health Perspect. 112 (2004) 1339-1340
61. Rao P.R., and Diwan P.V. Permeability studies of cellulose acetate free films for transdermal use: influence of plasticicers. Pharm. Acta Helv. 72 (1997) 47-51
62. Regnier, J., Bowden, C., Lhuguenot, L., 2004. Effects on rat embryonic development in vitro of di-(2-ethylhexyl) phthalate (DEHP) and its metabolites. 187. The Toxicologist CD - An official Journal of the Society of Toxicology 78, 1-S.
63. Schettler T. Human exposure to phthalates via consumer products. Int. J. Androl. 29 (2006) 134-139 discussion 181-5
64. Sheldon, L., Whitaker, D., Keever, J., Clayton, A., Perritt, R., 1993. Phthalates and PAHs in indoor and outdoor air in a southern California community. In: Proceedings of Indoor Air 93, vol. 3.
65. Silva M., Barr D.B., Reidy J.A., Malek N.A., Hodge C.C., Caudill S.P., Brock J.W., Needham L.L., and Calafat A.M. Urinary levels of seven phthalate metabolites in the US population from the National health and Nutition Examination Survey (NHANES) 1999-2000. Environ. Health Perspect. 112 (2004) 331-338
66. Silva M.J., Reidy J.A., Preau J.L., Samandar E., Needham L.L., and Calafat A.M. Measurement of eight urinary metabolites of di(2-ethylhexyl) phthalate as biomarkers for human exposure assessment. Biomarkers 11 (2006) 1-13
67. Silva, M.J., Samandar, E., Preau Jr., J.L., Needham, L.L., Calafat, A.M., 2006b. Urinary oxidative metabolites of di(2-ethylhexyl) phthalate in humans. Toxicology 15;219(1-3), 22-32.
68. Stroheker T., Cabaton N., Nourdin G., Regnier J.F., Lhuguenot J.C., and Chagnon M.C. Evaluation of antiandrogenic activity of di-(2-ethylhexyl)phthalate. Toxicology 208 (2005) 115-121
69. Swan S.H., Main K.M., Liu F., Stewart S.L., Kruse R.L., Calafat A.M., Mao C.S., Redmon J.B., Ternand C.L., Sullivan S., and Teague J.L. Study for Future Families Research Team 2005. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ. Health Perspect. 113 (2005) 1056-1061
70. Tickner J.A., Schettler T., Guidotti T., McCally M., and Rossi M. Health risks posed by use of di-2-ethylhexyl phthalate (DEHP) in PVC medical devices: a critical review. Am. J. Ind. Med. 39 (2001) 100-111
71. Tsumura Y., Ishimitsu S., Saito I., Sakai H., Kobayashi Y., and Tonogai Y. Eleven phthalate esters and di(2-ethylhexyl) adipate in one-week duplicate diet samples obtained from hospitals and their estimated daily intake. Food Addit. Contam. 18 (2001) 449-640
72. Tsumura Y., Ishimitsu S., Saito I., Sakai H., Tsuchida Y., and Tonogai Y. Estimated daily intake of plasticizers in 1-week duplicate diet samples following regulation of DEHP-containing PVC gloves in Japan. Food Addit. Contam. 20 (2003) 317-334
73. US EPA Integrated Risk Information System (IRIS), 1990. Dibutyl phthalate 〈www.epa.gov/iris/subst/0038.htm〉.
74. US EPA Integrated Risk Information System (IRIS), 1991. Di(2-ethylhexyl)phthalate (DEHP) 〈www.epa.gov/iris/subst/0014.htm〉.
75. US EPA Integrated Risk Information System (IRIS), 1993a. Butyl benzyl phthalate 〈www.epa.gov/iris/subst/0293.htm〉.
76. US EPA Integrated Risk Information System (IRIS), 1993b. Dietyl phthalate 〈www.epa.gov/iris/subst/0226.htm〉.
77. US FDA (US Food and Drug Administration), 2000. Indirect food additives: adhesives and components of coatings adhesives, 〈http://www.access.gpo.gov/nara/cfr/waisidx-00/21cfr175-00.html〉.
78. US FDA (US Food and Drug Administration). Safety Assessment of Di(2-ethylhexyl)Phthalate (DEHP) Release from Medical Devices (2002), US Food and Drug Administration, Washington, DC. http://www.fda.gov/cdrh/ost/dehp-pvc.pdf
79. US FDA (US Food and Drug Administration). Inactive Ingredient Search for Approved Drug Products (2003), US Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, MD. http://www.access-data.fda.gov/scripts/cder/iig/index.cfm
80. Wams T.J.U. Diethylhexylphthalate as an environmental contaminant - a review. Sci. Tot. Environ. 66 (1987) 1-16
81. Wittassek M., Heger W., Koch H.M., Becker K., Angerer J., and Kolossa-Gehring M. Daily intake of di(2-ethylhexyl)phthalate (DEHP) in German children-a comparison of two estimation models based on urinary DEHP metabolite levels. Int. J. Hyg. Environ. Health 210 (2007) 35-42
82. Wittassek M., Wiesmüller G.A., Koch H.M., Eckhard R., Dobler L., Müller J., Angerer J., and Schlüter C. Internal phthalate exposure over the last two decades-a retrospective human biomonitoring study. Int. J. Hyg. Environ. Health 210 (2007) 319-333
83. Wormuth M., Scheringer M., Vollenweider M., and Hungerbuhler K. What are the sources of exposure to eight frequently used phthalic acid esters in Europeans?. Risk Anal. 26 (2006) 803-824